UNMC Psychopharmacology Research Consortium

• Home
• Overview
• Faculty & Staff
  • William J. Burke, M.D.
  • Christopher J. Kratochvil, M.D.
  • William H. Roccaforte, M.D.
  • Steven P. Wengel, M.D.
  • Thomas Magnuson, M.D.
  • Dennis P. McNeilly, Psy. D.
  • Martin Wetzel M.D.
• Resources
• Current Research
  • Depression Studies
  • Alzheimer's Disease Studies
  • ADHD Disorder Studies
  • Adult ADHD Study
  • Gambling
• Maps & Directions
• Contact Information
• FAQs
• Links
• Psychiatry Department

The Psychopharmacology Research Consortium is a division of the University of Nebraska Department of Psychiatry. The Department combines the teaching, research, and clinical service activities in psychiatry for the College of Medicine of the University of Nebraska Medical Center. We are located in Omaha, Nebraska and provide medical services for an extended area of eastern Nebraska and western Iowa.  

The Psychopharmacology Research Consortium was organized in 1984 to investigate pharmacologic approaches to the treatment of mental disorders. 

The Consortium works in conjunction with the National Institutes of Health (NIH) as well as pharmaceutical companies in the evaluation of potentially innovative treatments for a wide range of disorders in adults and children. All studies are approved by the University of Nebraska Institutional Review Board which serves to protect the rights of persons who participate in research studies.